Other

Derivatives

Pfizer Derivatives increased by 33.6% to $155.00M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2021
Last reportedQ2 2025

How to read this metric

An increase suggests the company is locking in favorable long-term pricing for its operational inputs.

Detailed definition

This represents the fair value of derivative financial instruments that are expected to be settled or realized beyond th...

Peer comparison

Reflects the duration of the company's hedging strategy compared to industry peers.

Metric ID: other_derivative_assets_noncurrent

Historical Data

2 periods
 Q4 '25Q1 '26
Value$116.00M$155.00M
QoQ Change+33.6%
Range$116.00M$155.00M

Frequently Asked Questions

What is Pfizer's derivatives?
Pfizer (PFE) reported derivatives of $155.00M in Q1 2026.
What does derivatives mean?
The value of derivative contracts expected to be settled after one year that are currently in the company's favor.